Is Avastin the right choice of treatment for retinopathy of prematurity?
Acta Paediatrica, Stockholm, Sweden. anna.kall@karolinska.se
Anna
A
Käll
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D000068258:Bevacizumab; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D056687:Off-Label Use; D012178:Retinopathy of Prematurity / Q000188:drug therapy*; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab